Abstract
Cancer is a very heterogeneous group of diseases resulting from the interactions of genetic and environmental factors in terms of etiology. Enhanced knowledge of cancer genetics with rapidly developing genetic technologies, especially the next-generation sequencing systems, allows us to better understand the biology of cancer. Genetic studies in sporadic and hereditary cancers benefit many areas, including understanding the genetic etiology of cancer, identifying individuals at risk, making the correct diagnosis, determining and monitoring the patient's prognosis, using individualized treatment options, and developing new treatment modalities. Cancers arise due to the accumulation of genetic alterations within a cell. So that all cancers can be defined as genetic, but only a small portion of all cancers are inherited. The majority of genetic changes that lead to abnormal proliferation, clonal expansion, invasion of the cancer cells into surrounding tissues, and distant metastases are somatic alterations that occur during normal cell division and cannot pass on to offspring. However, some individuals with hereditary cancer syndromes have genetic changes that predispose them to an increased risk for certain cancers, and these changes can be passed on from one generation to the next. In this chapter, after briefly mentioning the basic principles in cancer genetics and mechanisms of molecular carcinogenesis, we discuss the genetic approach to hereditary cancer syndromes and describe hereditary cancer syndromes that are relatively common in the clinic in detail.